Answers are grounded in this paper and cite their sources.
Background/Objectives: Failure to recognize high-flow nasal cannula (HFNC) failure early may delay intubation and worsen clinical outcomes. We investigated whether the early physiological response to HFNC and erector spinae muscle (ESM) area at admission were associated with HFNC failure in pneumonia-related acute respiratory failure. Methods: This single-center retrospective observational cohort study included adults who received HFNC within 24 h of intensive care unit admission between 2019 and 2023. HFNC failure was defined as intubation within 7 days. The Respiratory Rate–Oxygenation (ROX) index was measured before HFNC initiation. For days 1 and 2, the best response ROX index was retrospectively defined as the ROX value corresponding to the highest PaO2/ fraction of inspired oxygen ratio within each 24 h assessment window, rather than as a measurement obtained at a prespecified time point. The ESM area at T12 was measured on admission. Longitudinal changes in the ROX index and factors associated with HFNC failure were evaluated. Results: Among 94 patients, 21 experienced HFNC failure. The admission ROX index did not differ significantly between the groups (3.4 versus 3.6). The median best response ROX indices in the success and failure groups were 10.7 versus 6.6 on day 1 and 10.5 versus 6.4 on day 2. ROX improvement was significantly smaller in the failure group on both days. The day 1 best response ROX index had an area under the receiver operating characteristic curve of 0.731 (95% confidence interval [CI], 0.611–0.851). In the primary analysis using Firth penalized logistic regression (85 patients, including 17 HFNC failures), a lower day 1 best response ROX index (adjusted odds ratio [OR] per unit increase, 0.818; 95% CI, 0.692–0.931) and a smaller admission ESM area (adjusted OR per 100 mm2 increase, 0.939; 95% CI, 0.872–0.999) were associated with HFNC failure. Conclusions: The day 1 best response ROX index and admission ESM area were associated with HFNC failure. However, their clinical utility remains uncertain, and prospective multicenter studies with standardized assessment protocols and external validation are warranted.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: